Clinical Trials Directory

Trials / Conditions / Developmental and Epileptic Encephalopathy

Developmental and Epileptic Encephalopathy

8 registered clinical trials studyying Developmental and Epileptic Encephalopathy — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDevelopmental and Epileptic Encephalopathies Diagnosed Via Long-read Genome Sequencing
NCT07396883
University Hospital, Strasbourg, France—
SuspendedA Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Enceph
NCT06983158
Capsida Biotherapeutics, Inc.Phase 1 / Phase 2
Enrolling By InvitationA Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
NCT06908226
Longboard PharmaceuticalsPhase 3
RecruitingA Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
NCT06719141
Longboard PharmaceuticalsPhase 3
RecruitingDevelopmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data
NCT06380192
Imagine Institute—
CompletedOpen-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
NCT05626634
Longboard PharmaceuticalsPhase 2
CompletedStudy to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
NCT05364021
Longboard PharmaceuticalsPhase 1 / Phase 2
Active Not RecruitingPhenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy
NCT04937062
Weill Medical College of Cornell UniversityEARLY_Phase 1